The effect of heparin infusion intensity on outcomes for bridging hospitalized patients with atrial fibrillation

par Warden, Bruce A., Diep, Calvin, Ran, Ran, Thomas, Matthew, Cigarroa, Joaquin E.
Publié dans Clin Cardiol (2019)

Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion

par Warden, Bruce A., MacKay, John, Jafari, Melika, Willman, Alana, Stecker, Eric C.
Publié dans J Am Heart Assoc (2018)

Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients

par Warden, Bruce A., Kaufman, Tina, Minnier, Jessica, Duell, P. Barton, Fazio, Sergio, Shapiro, Michael D.
Publié dans JACC Case Rep (2020)

Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practice

par Warden, Bruce A., Purnell, Jonathan Q., Duell, P. Barton, Craigan, Courtney, Osborn, Diane, Cabot, Emily, Fazio, Sergio
Publié dans Am J Prev Cardiol (2021)

Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement

par Warden, Bruce A., Steiner, Johannes, Camacho, Albert, Nguyen, Khoa, Purnell, Jonathan Q, Barton Duell, P., Craigan, Courtney, Osborn, Diane, Fazio, Sergio
Publié dans Am J Prev Cardiol (2021)

Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol

par Warden, Bruce A., Miles, Joshua R., Oleaga, Carlota, Ganda, Om P., Duell, P. Barton, Purnell, Jonathan Q., Shapiro, Michael D., Fazio, Sergio
Publié dans Am J Prev Cardiol (2020)

Application of PCSK9 Inhibitors in Practice: Part 2 – The Patient Experience

par Kaufman, Tina M., Warden, Bruce A., Minnier, Jessica, Miles, Joshua R., Duell, P. Barton, Purnell, Jonathan Q., Wojcik, Cezary, Fazio, Sergio, Shapiro, Michael D.
Publié dans Circ Res (2019)